Author Archives for gretchen.ladish

HDR UK opens applications for Health Data Science Black Internship Programme 2022

November 26, 2021 12:55 pm Published by Leave your thoughts

About the programme Overview Run by Health Data Research UK (HDR UK) and the UK Health Data Research Alliance (the ‘Alliance’) in partnership with 10,000 Black Interns initiative, our Health Data Science Black Internship Programme provides an exciting new endeavour for early career Black data scientists who are currently heavily under-represented within the health data science. Our Health Data Science Black Internship Programme is just...


HDR UK and Barts Life Sciences are recruiting for a health data scientist

November 16, 2021 4:03 pm Published by Leave your thoughts

An exciting opportunity for a healthcare data scientist – the post holder will support cross regional data analysis for a project which is enabling regional, acute hospital admissions data to support vaccine safety research. To enable surveillance and research on the COVID-19 vaccination programme and other rare events there is a critical need for rapid, near real time and more...


Barts Life Sciences opens new talent hub at Newham College

October 21, 2021 2:23 pm Published by Leave your thoughts

In an effort to encourage more young people to work for the NHS, Barts Life Sciences, a joint research programme led by Barts Health NHS Trust and Queen Mary University of London, have opened a new training facility for health care and life sciences in east London in partnership with Newham College. The facility – known as the Barts Health...


Barts Life Sciences is recruiting for a digital fellow

October 21, 2021 10:11 am Published by Leave your thoughts

Barts Life Sciences is recruiting for a digital fellow for our programme of AI and machine learning projects, CAP-AI. This project, ThyrAI, will develop automatic interpretation of thyroid biopsy specimen slides for automated diagnosis using machine and deep learning approaches. Computer programs can then be devised for feature extraction from image data and feeding of this information to classifiers for...


OPTIMA: Improving treatment for patients with prostate, breast and lung cancer through artificial intelligence

October 13, 2021 8:28 am Published by Leave your thoughts

Professors Claude Chelala and Louise Jones from Barts Cancer Institute, Queen Mary University of London, are part of a €21.3 million public-private research programme that will seek to use artificial intelligence (AI) to improve care for patients with prostate, breast and lung cancer. The aim of the research project, named OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence), is to design, develop and...


Queen Mary researchers including Director of Barts Life Sciences Rakesh Uppal help develop nasal spray that prevents Covid-19

September 27, 2021 2:19 pm Published by Leave your thoughts

Queen Mary University of London professors Rakesh Uppal and Áine McKnight have been at the centre of a new clinical trial finding that pHOXWELL – a nasal spray developed by biotech company pHOXBIO – reduced SARS-CoV-2 infection by 63 per cent in the group given pHOXWELL compared to the group given the placebo. SARS-CoV-2 is the virus that causes Covid-19....


AI technology at Barts Life Sciences spares at-risk diabetic patients from limb amputation

September 2, 2021 9:42 am Published by Leave your thoughts

Thousands of diabetes patients could be spared a limb amputation thanks to ground-breaking AI technology that has helped Barts Life Sciences identify people at risk from complications. Clinicians at Barts Health NHS Trust, one of the largest trusts in the UK, say it would have taken a clinician over 100 years to review the volume of data analysed in a...


AI revolution at Barts Health NHS Trust could help thousands of diabetes patients avoid leg and foot amputations

August 12, 2021 11:11 am Published by Leave your thoughts

Clinithink artificial intelligence software takes just weeks to sift through data that would take a human more than a century – enabling quicker treatment that could save limbs The Clinithink software analysed 14.2 million medical records and notes to identify patients with diabetic foot disease. A new AI technology being trialled at a major NHS hosptial trust could transform treatment...


Barts Life Sciences CEO Professor Sir Mark Caulfield to give keynote address at SEHTA MedTech conference October 2021

August 11, 2021 4:03 pm Published by Leave your thoughts

Barts Life Sciences and SEHTA are delighted to announce that Professor Sir Mark Caulfield, CEO of Barts Life Sciences will be the keynote speaker at the SEHTA 2021 International MedTech Expo & Conference. About the conference: Friday 8th October 2021, Hilton London Tower Bridge Hotel www.sehtamedtechexpo.co.uk The SME focused healthcare event driving collaborations between business, care, clinicians & academics Improving...